Endotoxin

An endotoxin is a toxic component of the outer cell wall of certain bacteria, released when the bacteria break down. When it contaminates an injectable product, it can cause fever, chills, low blood pressure, and other serious reactions, even if the product no longer contains live bacteria.

Controlling endotoxin levels is a routine part of regulated sterile drug manufacturing. It is a documented risk with unregulated or grey-market peptides and injectables made without that oversight, which is one reason the source and quality controls of an injected product matter.

Related terms

503B outsourcing facility — An FDA-registered compounding facility that can make larger batches under CGMP standards and FDA inspection — a step above 503A, but still not an FDA-approved manufactured drug.

503A compounding — A section of federal law that lets a licensed pharmacy compound a medication for an individual patient's prescription, outside the FDA approval process.

Related guides

How compounded GLP-1 medications are made — and how that differs from the branded pens — A compounded GLP-1 isn't a knockoff pen off a production line — it's mixed from raw active ingredient at a pharmacy. Here's how the drug substance is sourced, how the formula and dose are set, how a sterile compounding pharmacy actually makes the vial, and how all of that compares with the tightly controlled, FDA-approved process behind Ozempic, Wegovy, and Zepbound.

How to verify a pharmacy is legitimate: BeSafeRx, NABP, and your state board — Our sourcing guides keep ending on the same instruction — verify the pharmacy with your state board, the NABP, or FDA's BeSafeRx — without saying how. This is the step-by-step: the free tools each one offers, what red flags to look for, how to pull a pharmacy's license record, and how to check your own pen's lot number against FDA's counterfeit alerts. About five minutes, start to finish.

Pharmacy sources for GLP-1 medications: compounded, telehealth, and counterfeit risks — The brand shortages that made compounded GLP-1s widely available ended in 2025, and the sourcing landscape has shifted — counterfeit Ozempic has turned up in the legitimate supply chain three times. Here's how to tell the fully legitimate routes from compounded grey areas and outright dangerous sellers, and how to vet any source before you inject.

"Research peptides" and GLP-1 medications: what they are, and what the label doesn't tell you — "Research peptides" are GLP-1 drugs — semaglutide, tirzepatide, retatrutide — sold as powder in vials stamped "research use only, not for human consumption." That label is a legal workaround, not a safety statement. Here's where these products come from, what independent testing actually found inside the vials, why the "research" disclaimer doesn't make them regulated or safe, and the documented harms driving a spike in poison-control calls.